tiprankstipranks
Trending News
More News >
Jubilant Pharmova Limited (IN:JUBLPHARMA)
:JUBLPHARMA
India Market

Jubilant Pharmova Limited (JUBLPHARMA) Income Statement

Compare
1 Followers

Jubilant Pharmova Limited Income Statement

Last quarter (Q4 2025), Jubilant Pharmova Limited's total revenue was ₹19.29B, an increase of 9.68% from the same quarter last year. In Q4, Jubilant Pharmova Limited's net income was ₹1.54B. See Jubilant Pharmova Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 72.34B₹ 66.45B₹ 62.19B₹ 60.59B₹ 59.64B
Gross Profit
₹ 49.17B₹ 19.06B₹ 43.41B₹ 42.72B₹ 42.10B
Operating Expenses
₹ 22.68B₹ 14.45B₹ 41.19B₹ 34.48B₹ 30.92B
Depreciation and Amortization
₹ 3.69B₹ 3.82B₹ 5.54B₹ 3.82B₹ 3.49B
EBITDA
₹ 11.74B₹ 8.09B₹ 7.58B₹ 11.68B₹ 13.93B
Operating Income
₹ 26.50B₹ 5.19B₹ 3.75B₹ 8.40B₹ 11.44B
Other Income/Expenses
₹ -16.69B₹ -3.48B₹ -3.47B₹ -1.85B₹ -2.39B
Pretax Income
₹ 9.81B₹ 1.71B₹ 277.80M₹ 6.30B₹ 8.71B
Net Income
₹ 8.39B₹ 771.00M₹ -609.80M₹ 4.14B₹ 8.36B
Per Share Metrics
Basic EPS
₹ 52.99₹ 4.86₹ -3.83₹ 26.01₹ 52.48
Diluted EPS
₹ 52.85₹ 4.85₹ -3.83₹ 26.01₹ 52.48
Weighted Average Shares Outstanding
158.83M 158.51M 159.15M 159.17M 159.27M
Weighted Average Shares Outstanding (Diluted)
158.83M 158.86M 159.15M 159.17M 159.27M
Currency in INR

Jubilant Pharmova Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis